Sangamo Therapeutics, Inc. Tech Stack

Sangamo Therapeutics, Inc. uses 8 technology products and services including OneTrust, Microsoft Outlook, TweenMax, and more. Explore Sangamo Therapeutics, Inc.'s tech stack below.

  • OneTrust
    Cookie Compliance
  • Microsoft Outlook
    Email
  • TweenMax
    Javascript Frameworks
  • Google
    Miscellaneous
  • Amazon Web Services
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Akamai Bot Manager
    Security
  • Bootstrap
    UI Frameworks

Media & News

Sangamo Therapeutics, Inc.'s Email Address Formats

Sangamo Therapeutics, Inc. uses at least 4 format(s):
Sangamo Therapeutics, Inc. Email FormatsExamplePercentage
first@sangamo.comJohn@sangamo.com
40%
fmiddlelast@sangamo.comJMichaelDoe@sangamo.com
30%
lastfi@sangamo.comDoeJo@sangamo.com
20%
last@sangamo.comDoe@sangamo.com
10%

Frequently Asked Questions

Where is Sangamo Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s main headquarters is located at 7000 Marina Blvd Brisbane, California 94005 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Sangamo Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Sangamo Therapeutics, Inc.'s main corporate office by phone at +1-510-970-6000. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sangamo Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc. is a publicly traded company; the company's stock symbol is SGMO.

What is Sangamo Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s official website is sangamo.com and has social profiles on LinkedIn.

How much revenue does Sangamo Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of February 2024, Sangamo Therapeutics, Inc.'s annual revenue reached $75M.

What is Sangamo Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sangamo Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2024, Sangamo Therapeutics, Inc. has approximately 390 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: S. M.Chief Executive Officer And President: A. M.Chief Of Staff To Ceo: B. D.. Explore Sangamo Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Sangamo Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Sangamo Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s tech stack includes OneTrustMicrosoft OutlookTweenMaxGoogleAmazon Web ServicesYoast SEOAkamai Bot ManagerBootstrap.

What is Sangamo Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s email format typically follows the pattern of first@sangamo.com. Find more Sangamo Therapeutics, Inc. email formats with LeadIQ.

How much funding has Sangamo Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2024, Sangamo Therapeutics, Inc. has raised $146M in funding. The last funding round occurred on Apr 03, 2019.

When was Sangamo Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc. was founded in 1995.
Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com.

Section iconCompany Overview

Headquarters
7000 Marina Blvd Brisbane, California 94005 US
Phone number
+1-510-970-6000
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SGMO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1995
Employees
201-500

Section iconFunding & Financials

  • $146M

    Sangamo Therapeutics, Inc. has raised a total of $146M of funding over 6 rounds. Their latest funding round was raised on Apr 03, 2019.

  • $50M$100M

    Sangamo Therapeutics, Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $146M

    Sangamo Therapeutics, Inc. has raised a total of $146M of funding over 6 rounds. Their latest funding round was raised on Apr 03, 2019.

  • $50M$100M

    Sangamo Therapeutics, Inc.'s revenue is in the range of $50M$100M

© LeadIQ, Inc. All rights reserved.